2024-09-07 |
[Correspondence] The need for point-of-care tests for mpox |
Ranu S Dhillon, Abraar Karan, Devabhaktuni Srikrishna, Jean-Vivien Mombouli |
|
2024-09-06 |
[Comment] Advancing the economics of health for all |
Mariana Mazzucato, Tedros Adhanom Ghebreyesus |
|
2024-09-04 |
[Correspondence] A crisis of safety: female health-care workers in India need reforms |
Gururaj Arakeri, Vishal Rao, Shankargouda Patil |
|
2024-09-04 |
[Comment] Addressing global gun violence: a Lancet Commission on Global Gun Violence and Health |
Adnan A Hyder, Lorena Barberia, Lancet Commission on Global Gun Violence and Health |
|
2024-09-03 |
[Department of Error] Department of Error |
|
|
2024-09-03 |
[Correspondence] Mpox in eastern Democratic Republic of the Congo: challenges and prospects for vaccination |
Harry César Kayembe Ntumba, Bien-Aimé Makasa Mandja |
|
2024-09-02 |
[Comment] Optical coherence tomography imaging for complex percutaneous coronary intervention |
Mamas A Mamas, Gary S Mintz |
|
2024-09-02 |
[Comment] How feasible is a cage-free solution for de novo coronary artery disease? |
Margaret B McEntegart, Ajay J Kirtane |
|
2024-09-02 |
[Articles] Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea |
Sung-Jin Hong, Seung-Jun Lee, Sang-Hyup Lee, Jong-Young Lee, Deok-Kyu Cho, Jin Won Kim, Sang Min Kim, Seung-Ho Hur, Jung Ho Heo, Ji-Yong Jang, Jin Sin Koh, Hoyoun Won, Jun-Won Lee, Soon Jun Hong, Dong-Kie Kim, Jeong Cheon Choe, Jin Bae Lee, Soo-Joong Kim, |
|
2024-09-02 |
[Articles] Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial |
Chao Gao, Xingqiang He, Fan Ouyang, Zhihui Zhang, Guidong Shen, Mingxing Wu, Ping Yang, Likun Ma, Feng Yang, Zheng Ji, Hua Wang, Yanqing Wu, Zhenfei Fang, Hong Jiang, Shangyu Wen, Yi Liu, Fei Li, Jingyu Zhou, Bin Zhu, Yunpeng Liu, Ruining Zhang, Tingting |
|
2024-09-02 |
[Articles] Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up |
Holger Thiele, Jacob E Møller, Jose P S Henriques, Margriet Bogerd, Melchior Seyfarth, Daniel Burkhoff, Petr Ostadal, Richard Rokyta, Jan Belohlavek, Steffen Massberg, Marcus Flather, Matthias Hochadel, Steffen Schneider, Steffen Desch, Anne Freund, Hans |
|
2024-09-02 |
[Comment] Optimal patient and mechanical circulatory support device selection in acute myocardial infarction cardiogenic shock |
Jacob C Jentzer, Benjamin Hibbert |
|
2024-09-01 |
[Articles] Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis |
Pardeep S Jhund, Atefeh Talebi, Alasdair D Henderson, Brian L Claggett, Muthiah Vaduganathan, Akshay S Desai, Carolyn S P Lam, Bertram Pitt, Michele Senni, Sanjiv J Shah, Adriaan A Voors, Faiez Zannad, Scott D Solomon, John J V McMurray |
|
2024-09-01 |
[Comment] Mineralocorticoid receptor antagonists for every patient with heart failure |
Frans H Rutten, Amy Groenewegen |
|
2024-08-31 |
[Articles] De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials |
Marco Valgimigli, Sung-Jin Hong, Felice Gragnano, Konstantina Chalkou, Anna Franzone, Bruno R da Costa, Usman Baber, Byeong-Keuk Kim, Yangsoo Jang, Shao-Liang Chen, Gregg W Stone, Joo-Yong Hahn, Stephan Windecker, Michael C Gibson, Young Bin Song, Zhen Ge |
|
2024-08-31 |
[Comment] Is this the conclusive evidence for ticagrelor monotherapy in acute coronary syndromes? |
Giulio G Stefanini, Angelo Oliva |
|
2024-08-31 |
[Correspondence] Mpox threat: Pakistan must act now |
Saad Javed, Nimirta Sahitia, Eesha Yaqoob |
|
2024-08-31 |
[Correspondence] Enhancing mpox response in Africa with implementation science |
Abdu A Adamu, Joseph Okeibunor, Reena H Doshi, Charles S Wiysonge |
|
2024-08-30 |
[Comment] GLP-1 receptor agonists in heart failure: how far to expand use? |
Camilla Hage |
|
2024-08-30 |
[Articles] Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials |
Mikhail N Kosiborod, John Deanfield, Richard Pratley, Barry A Borlaug, Javed Butler, Melanie J Davies, Scott S Emerson, Steven E Kahn, Dalane W Kitzman, Ildiko Lingvay, Kenneth W Mahaffey, Mark C Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, S |
|
2024-08-30 |
[Correspondence] Far-right riots in the UK: the culmination of years of rhetoric and policies |
Yamina Boukari, Delan Devakumar |
|
2024-08-30 |
[Correspondence] 6 months on: South Korean medical students still on leave |
Dongju Shin, Dong-Jin Shin |
|
2024-08-29 |
[Seminar] Primary biliary cholangitis |
Atsushi Tanaka, Xiong Ma, Atsushi Takahashi, John M Vierling |
|
2024-08-29 |
[Comment] Primary health-care practices for deaf children should include early incorporation of a signed language |
Wyatte C Hall, Julia L Hecht |
|
2024-08-27 |
[Correspondence] Bangladesh protests: law enforcement and public health crisis |
Md Abu Bakkar Siddik |
|
2024-08-24 |
[Correspondence] The health of migrants at the intersection of mpox and HIV |
Archibong Edem Bassey |
|
2024-08-23 |
[Correspondence] Strengthening community resilience: lessons from COVID-19 for mpox prevention |
Francesco Branda, Giancarlo Ceccarelli, Massimo Ciccozzi, Fabio Scarpa |
|
2024-08-22 |
[Seminar] X-linked hypophosphataemia |
Peter Kamenický, Karine Briot, Craig F Munns, Agnès Linglart |
|
2024-08-19 |
[Comment] The mpox emergency and the role of Gavi |
Sania Nishtar |
|
2024-08-19 |
[Editorial] Mpox: the need for a coordinated international response |
The Lancet |
|
2024-08-17 |
[Seminar] Obesity in adults |
Ildiko Lingvay, Ricardo V Cohen, Carel W le Roux, Priya Sumithran |
|
2024-08-17 |
[Viewpoint] International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches |
Johan L Dellgren, Govind Persad, Ezekiel J Emanuel |
|
2024-08-17 |
[Correspondence] Human rights considerations are key when choosing a conference location |
Shelagh B Coutts, Nikola Sprigg |
|
2024-08-17 |
[Comment] Transforming humanitarian aid through lived experience |
Kemish Kenneth Alier |
|
2024-08-15 |
[Comment] The Glasgow Coma Scale at 50: looking back and forward |
Geoffrey T Manley, Andrew IR Maas |
|
2024-08-13 |
[Comment] Nature-based solutions are essential for climate and health action |
Neil M Vora, Shweta Narayan, Aggrey Aluso, Camila I Donatti, Omnia El Omrani, Lee Hannah, Jemilah Mahmood, Nicaise Ndembi, Mariana M Vale, Elizabeth Willetts |
|
2024-08-09 |
[Comment] Integrating patient and public involvement and engagement in translational medicine |
Karen L Shaw, Melanie J Calvert, Persephone Borrow, Evelyn Chakera, Ronjon Chakraverty, Sarah E Hughes, Foram Khatsuria, Francesca A M Kinsella, Christel McMullan, Julie Richardson-Abraham, Vlada Yarosh, Olalekan Lee Aiyegbusi |
|
2024-08-07 |
[Review] New promises and challenges in the treatment of advanced non-small-cell lung cancer |
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, Federico Cappuzzo, Pasi A Jänne, Solange Peters, Fred R Hirsch |
|
2024-08-02 |
[Seminar] Acute liver failure |
Rakhi Maiwall, Anand V Kulkarni, Juan Pablo Arab, Salvatore Piano |
|
2024-08-01 |
[Comment] Sjögren's disease: a new era for clinical trials? |
Serena Colafrancesco, Roberta Priori |
|
2024-08-01 |
[Review] Long COVID: a clinical update |
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, Janko Ž Nikolich |
|
2024-08-01 |
[Articles] Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study |
Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A Pazo-Cid, Ferran Losa, Debbie GJ Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Michael Stahl, Frédéric Bigot, Sun Young Kim, Yo |
|
2024-08-01 |
[Comment] Molecular guided therapies: a practice-changing step forward in cancer of unknown primary management |
Elie Rassy, F Anthony Greco, Nicholas Pavlidis |
|
2024-08-01 |
[Articles] Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study |
Benjamin A Fisher, Xavier Mariette, Athena Papas, Thomas Grader-Beck, Hendrika Bootsma, Wan-Fai Ng, P L A van Daele, Stephanie Finzel, Ghaith Noaiseh, Sergio Elgueta, Josef Hermann, Sara S McCoy, Esen Akpek, Arthur Bookman, Monika Sopala, Michela Montecch |
|
2024-08-01 |
[The Lancet Commissions] Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission |
Gill Livingston, Jonathan Huntley, Kathy Y Liu, Sergi G Costafreda, Geir Selbæk, Suvarna Alladi, David Ames, Sube Banerjee, Alistair Burns, Carol Brayne, Nick C Fox, Cleusa P Ferri, Laura N Gitlin, Robert Howard, Helen C Kales, Mika Kivimäki, Eric B Larso |
|
2024-08-01 |
[Comment] Pivotal points in the science of dementia risk reduction |
Miia Kivipelto, Francesca Mangialasche, Kaarin J Anstey |
|
2024-07-26 |
[Articles] Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study |
Raed A Joundi, Bo Hu, Sumathy Rangarajan, Darryl P Leong, Shofiqul Islam, Eric E Smith, Erkin Mirrakhimov, Pamela Seron, Khalid F Alhabib, Batyrbek Assembekov, Jephat Chifamba, Rita Yusuf, Rasha Khatib, Camilo Felix, Afzalhussein Yusufali, Noushin Mohamma |
|
2024-07-26 |
[Comment] A novel treatment approach for atopic dermatitis |
Patrick M Brunner |
|
2024-07-26 |
[Viewpoint] Differentiating mortality risk of individual infants and children to improve survival: opportunity for impact |
James A Berkley, Judd L Walson, Rajiv Bahl, Nigel Rollins |
|
2024-07-26 |
[Seminar] Chronic lymphocytic leukaemia |
Nitin Jain, William G Wierda, Susan O'Brien |
|
2024-07-26 |
[Comment] Global disparities in activity limitations and use of assistive devices |
Ekaterina Zotcheva, Ellen Melbye Langballe |
|
2024-07-26 |
[Comment] Mexico's bold new law on adequate and sustainable nutrition |
Elisa Pineda, Mauricio Hernández-F, Ana G Ortega-Avila, Alexandra Jones, Juan A Rivera |
|
2024-07-25 |
[Comment] Many crises, one call to action: advancing gender equality in health in response to polycrises |
Rajat Khosla, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Sima Bahous, Debora Diniz, Sara Hossain, Natalia Kanem, Ulrika Karlsson, Laura Laski, Dina Mired, Catherine Russell, Tlaleng Mofokeng, Achim Steiner, Volker Türk, Johanna Riha |
|
2024-07-25 |
[Articles] Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials |
Jonathan I Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J Legat, Kim A Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C Szepietowski, Dorota Krasowska, Blanka Havlíčková, Moni |
|
2024-07-25 |
[Comment] Realigning the physical activity research agenda for population health, equity, and wellbeing |
Ding Ding, Sebastien Chastin, Deborah Salvo, Tracy Nau, Klaus Gebel, Miguel Adriano Sanchez-Lastra, Mengyun Luo, Inacio Crochemore-Silva, Ulf Ekelund, Adrian Bauman |
|
2024-07-24 |
[Perspectives] Mandy Cohen: public health advocate and Director of the US CDC |
Susan Jaffe |
|
2024-07-23 |
[Perspectives] Rochelle Burgess: disrupting the status quo in global mental health |
Rachael Davies |
|
2024-07-19 |
[Seminar] Renal cell carcinoma |
Matthew Young, Francesca Jackson-Spence, Luis Beltran, Elizabeth Day, Christina Suarez, Axel Bex, Thomas Powles, Bernadett Szabados |
|
2024-07-19 |
[Articles] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials |
Robert Bissonnette, Richard B Warren, Andreas Pinter, Tove Agner, Melinda Gooderham, Marie L A Schuttelaar, Marie-Noëlle Crépy, Luca Stingeni, Esther Serra-Baldrich, Keith Baranowski, Sofie Korn, Merle Kurvits, Ursula Plohberger, Natacha Strange Vest, Sib |
|
2024-07-19 |
[Comment] Hands-on: a novel JAK inhibitor for the treatment of chronic hand eczema |
Yael Renert-Yuval, Emma Guttman-Yassky |
|
2024-07-16 |
[Perspectives] Kathleen Maletic Neuzil: new Fogarty International Center leader |
Udani Samarasekera |
|
2024-07-13 |
[Comment] Unlocking the power of NHS research: a priority for the new UK Government |
Andrew Morris |
|
2024-07-12 |
[Therapeutics] Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment |
Torsten Zuberbier, Luis Felipe Ensina, Ana Giménez-Arnau, Clive Grattan, Emek Kocatürk, Kanokvalai Kulthanan, Pavel Kolkhir, Marcus Maurer |
|
2024-07-12 |
[Comment] Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions |
Anthony Muchai Manyara, Oriana Ciani, Rod S Taylor, SPIRIT-Surrogate and CONSORT-Surrogate Project team and Consensus Group |
|
2024-07-11 |
[Comment] Priorities for sickle cell disease global research and implementation |
Ambroise Wonkam, Nchangwi Syntia Munung, Aldiouma Guindo, Obiageli Nnodu |
|
2024-07-10 |
[Department of Error] Department of Error |
|
|
2024-07-10 |
[Comment] The UK Government's mandate for change must prioritise transformation of the public's health |
Kevin Fenton, Greg Fell, William Roberts, Margaret Rae |
|
2024-07-10 |
[Comment] CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma |
Maria-Luisa Schubert, Peter Dreger |
|
2024-07-10 |
[Articles] CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study |
Matthew J Frank, John H Baird, Anne Marijn Kramer, Hrishikesh K Srinagesh, Shabnum Patel, Annie Kathleen Brown, Jean S Oak, Sheren F Younes, Yasodha Natkunam, Mark P Hamilton, Yi-Jiun Su, Neha Agarwal, Harshini Chinnasamy, Emily Egeler, Sharon Mavroukakis |
|
2024-07-09 |
[Comment] Self-guided digital acceptance and commitment therapy as a treatment option for fibromyalgia |
Guilherme Torres Vilarino |
|
2024-07-09 |
[Articles] Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial |
R Michael Gendreau, Lance M McCracken, David A Williams, Juan V Luciano, Yifei Dai, Nicolette Vega, Zunera Ghalib, Kristen Guthrie, Allison C Kraus, Michael J Rosenbluth, Ben Vaughn, Jennifer M Zomnir, Dana Reddy, Andrea L Chadwick, Daniel J Clauw, Lesley |
|
2024-07-06 |
[Correspondence] Counting the dead in Gaza: difficult but essential |
Rasha Khatib, Martin McKee, Salim Yusuf |
|
2024-07-05 |
[Comment] Physician associates in the UK and the role of the doctor |
Jessamy Bagenal |
|
2024-07-04 |
[Articles] Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial |
Peter Borchmann, Justin Ferdinandus, Gundolf Schneider, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Hänel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M Zij |
|
2024-07-04 |
[Comment] The CONCORD–Lancet Global Commission on Cancer |
Claudia Allemani, Gulnar Azevedo e Silva, Prashant Mathur, Michel P Coleman |
|
2024-07-02 |
[Comment] Non-communicable diseases: can implementation research change the game for policy and practice? |
Kumanan Rasanathan, Phyllis Dako-Gyeke, Wanrudee Isaranuwatchai, Yodi Mahendradhata, Morven Roberts, Giulia Loffreda, Sarah Rylance, Bente Mikkelsen |
|
2024-06-29 |
[Correspondence] Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis |
I Sermet-Gaudelus, Sihem Benaboud, Stéphanie Bui, Tiphaine Bihouée, Sophie Gautier, MODUL-CF study group |
|
2024-06-28 |
[Articles] Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial |
Jiamin Liu, Yan Li, Jinzhuo Ge, Xiaofang Yan, Haibo Zhang, Xin Zheng, Jiapeng Lu, Xi Li, Yan Gao, Lubi Lei, Jing Liu, Jing Li, ESPRIT Collaborative Group |
|
2024-06-28 |
[Comment] Mounting evidence in favour of the lower, the better blood pressure paradigm |
Kazem Rahimi |
|
2024-06-28 |
[Comment] Delivering the promise of improved health for women and girls in England |
Jane Elizabeth Hirst, Alice Witt, Edward Mullins, Kate Womersley, Dorcus Muchiri, Robyn Norton |
|
2024-06-27 |
[Seminar] Neonatal bacterial sepsis |
Tobias Strunk, Eleanor J Molloy, Archita Mishra, Zulfiqar A Bhutta |
|
2024-06-27 |
[Articles] Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial |
Vu N A Ho, Toan D Pham, Nam T Nguyen, Rui Wang, Robert J Norman, Ben W Mol, Tuong M Ho, Lan N Vuong |
|
2024-06-27 |
[Correspondence] Implications of suboptimal measles immunity in UK health-care workers |
Antonia Ho, Oliver Galgut, Sian Faustini, Nicholas Peters, Adrian Shields, Paul Klenerman, Susan Hopkins, Victoria Hall, Susanna Dunachie, Alex Richter |
|
2024-06-27 |
[Correspondence] Floods in south Brazil: more than an environmental crisis |
Guilherme Pinheiro Machado |
|
2024-06-27 |
[Comment] Efficiency and drawbacks of frozen embryo transfers from artificial versus natural cycles |
Anja Pinborg, Kristine Løssl |
|
2024-06-27 |
[Correspondence] Diabetes management amidst floods in Brazil |
Lucas Strassburger Matzenbacher, Janine Alessi, Gabriela Heiden Telo |
|
2024-06-26 |
[Correspondence] Oral diseases in Palestine |
David T Zhu, Kate Zinszer, Samer Abuzerr |
|
2024-06-21 |
[Seminar] Colorectal cancer |
Cathy Eng, Takayuki Yoshino, Erika Ruíz-García, Nermeen Mostafa, Christopher G Cann, Brittany O'Brian, Amala Benny, Rodrigo O Perez, Chiara Cremolini |
|
2024-06-21 |
[Series] Pathophysiology from preconception, during pregnancy, and beyond |
Marie-France Hivert, Helena Backman, Katrien Benhalima, Patrick Catalano, Gernot Desoye, Jincy Immanuel, Christopher J D McKinlay, Claire L Meek, Christopher J Nolan, Uma Ram, Arianne Sweeting, David Simmons, Alicia Jawerbaum |
|
2024-06-21 |
[Series] Epidemiology and management of gestational diabetes |
Arianne Sweeting, Wesley Hannah, Helena Backman, Patrick Catalano, Maisa Feghali, Willliam H Herman, Marie-France Hivert, Jincy Immanuel, Claire Meek, Maria Lucia Oppermann, Christopher J Nolan, Uma Ram, Maria Inês Schmidt, David Simmons, Tawanda Chivese, |
|
2024-06-21 |
[Series] Call to action for a life course approach |
David Simmons, Yashdeep Gupta, Teri L Hernandez, Naomi Levitt, Mireille van Poppel, Xilin Yang, Christina Zarowsky, Helena Backman, Maisa Feghali, Karoline Kragelund Nielsen |
|
2024-06-21 |
[Editorial] Non-communicable diseases in reproductive care |
The Lancet |
|
2024-06-20 |
[Articles] Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial |
Natasha C Pocovi, Chung-Wei Christine Lin, Simon D French, Petra L Graham, Johanna M van Dongen, Jane Latimer, Dafna Merom, Anne Tiedemann, Christopher G Maher, Ornella Clavisi, Shuk Yin Kate Tong, Mark J Hancock |
|
2024-06-20 |
[Comment] Physical activity to prevent recurrences of low back pain |
Diarmuid Denneny, Jackie Walumbe |
|
2024-06-18 |
[Comment] Political courage needed to prevent the next pandemic |
Helen Clark, Mauricio Cárdenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, Henry E Mark, Rosemary McCarney, Christine McNab, David Miliband, Anders Nordström, Thoraya Ahmed Obaid, Raj Panjabi, Elizabeth Radin, George Werner, Ellen Johnson Sirleaf |
|
2024-06-18 |
[Comment] The updated International Health Regulations: good news for global health equity |
Ashley Bloomfield, Abdullah Assiri |
|
2024-06-15 |
[Seminar] Peptic ulcer disease |
Majid A Almadi, Yidan Lu, Ali A Alali, Alan N Barkun |
|
2024-06-14 |
[Articles] Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial |
Amber Meulenbeld, Steven Ramondt, Maike G Sweegers, Franke A Quee, Femmeke J Prinsze, Emiel O Hoogendijk, Dorine W Swinkels, Katja van den Hurk |
|
2024-06-14 |
[Comment] A programme for greater health equity for the next UK Government |
Michael Marmot, Jessica Allen |
|
2024-06-14 |
[Department of Error] Department of Error |
|
|